In all fairness to the company, the complexity of the model and process is such that no-one could possibly lock in a timeline at this point with so many hurdles to jump and boxes to tick.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025